Terms ending in 2039
Every in-force patent on Cerevasc, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,013,900 | Systems and Methods for Minimally Invasive Drug Delivery to a Subarachnoid Space In force · High confidence | Cerevasc, LLC | In force | High confidence | |
| US 11,951,270 | Systems and Methods for Endovascularly Accessing a Subarachnoid Space In force · Medium confidence | Cerevasc, Inc. | In force | Medium confidence | |
| US 11,771,875 | Catheter Systems and Methods for Medical Procedures Using Catheters In force · High confidence | Cerevasc, Inc. | In force | High confidence | |
| US 11,850,390 | Systems and Methods for Minimally Invasive Drug Delivery to a Subarachnoid Space In force · High confidence | Cerevasc, Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.